Vaccinations Flashcards
DTaP
Diphtheria, Tetanus, Pertussis DT-Toxoid vaccines Pertussis -Subunit vaccine 5-dose series Administered: 2,4,6, 15-18 months, 4-6 year olds
Tdap or Td
Tdap: Tetanus, Diphtheria, Pertussis
Td: Tetanus-Diphtheria, is given to adolescents and adults
11-19yo: one-time dose Tdap, then Td every 10 years unless injured
Pregnant women should receive Tdap in the third trimester of each of their pregnancies
Adolescents and adults who have close contact with an infant <12 months should receive Tdap
Haemophilus Influenzae type b (Hib)
-Conjugate vaccine- Haemophilus Influenzae type b was a common cause of epiglottitis, meningitis, and bacteremia (bacteria in the blood)
Administered: 2,4,6, 12-15 months
Rotavirus (RV)
Live, oral vaccine 2,4, +/- 6mos 2 vaccines, equal efficacy Rotateq®: 2,4,6 months Rotarix®: 2,4 months
Pneumococcus (PCV13)
13 valent conjugate vaccine
Strep pneumoniae is a primary cause of bacterial disease: pneumonia, meningitis, bacteremia
Strep pneumoniae also a primary cause of otitis media
Administered: 2,4,6,12-15mos
Pneumococcal (PPSV23)
Polysaccharide vaccine
Children 2 and older with specific medical conditions
E.g.: Sickle cell disease, cochlear implant, asplenia, leukemia
All adults 65 and older-one time dose
Adults younger than 65 with specific medical conditions
Residents of nursing homes or long-term care facilities
Adults who smoke cigarettes
Polio (IPV)
Inactivated polio vaccine
Administered: 2,4,6-18mos,4-6yrs
Measles, Mumps, Rubella (MMR)
Administered: 12-15mos, 4-6yrs
Adults born prior to 1957 are considered immune
Adults born after 1957 must have documentation of 1 or more doses or lab evidence of immunity
Varicella (VAR)
Goal is to prevent complications from varicella-zoster virus including: pneumonia, meningitis
Administered: 12-15mos, 4-6 yrs
Teens and adults: 2 doses 4-8 weeks apart if no evidence or prior immunity
Prior to the vaccine 100-150 people died yearly secondary to complications of varicella infection (cdc.gov)
Hepatitis A (HepA)
Inactivated vaccine Hepatitis A: self-limited viral inflammation of liver Source: contaminated food and water Administered: 12mos, 18-24mos Adults at high risk from lifestyle or medical conditions MSM- man sex IVDU- intravenous drug use Research involving Hep A Travel
Hepatitis B (HepB)
Subunit vaccine
Liver disease, in some patients can lead to liver cancer or cirrhosis
Administered: Birth, 1-2mos, 6-18 mos
Adults at high risk from lifestyle, medical conditions, or occupation (health care providers)
Human Papillomavirus (HPV)
Indicated for prevention of cervical cancer
Quadrivalent protects against cervical cancer, genital warts, and cancers of the vagina, vulva, anus
Inactivated subunit vaccine
Recommended for females 11- 26 years and males 11-21 years
Males ages 22-26 may be vaccinated
Schedule: 0, 1-2, 6 months
HPV4: 6,11,16,18 indicated for males and females
HPV2: 16, 18 indicated for females
Meningococcal
MenACWY-D (Menactra)
MenACWY-CRM (Menveo)
Conjugate vaccines
Quadrivalent
Prevents disease by Neisseria meningitidis
Single dose of either Menactra or Menveo at age 11-12 with a booster at age 16
Children with sickle cell disease or other high risk conditions may receive a 4-dose infant series of Menveo
2 doses of Menactra or Menveo at least 2 months apart to adults with asplenia or persistent complement component deficiencies
Menomune is a polysaccharide vaccine
Indicated for adults 56 years and older with certain medical conditions
Influenza vaccine
All persons 6 months and older should be vaccinated annually
Persons 6 mos and older can receive the inactivated influenza vaccine (IIV)
-Recombinant-
Persons 2-49 yo who are healthy, non-pregnant can receive either the live, attenuated influenza vaccine (LAIV) or IIV
Health care workers who care for severely immunocompromised persons should receive IIV
Adults 65 and older can receive the standard dose IIV or high-dose IIV
Influenza Terms
Trivalent=Influenza A (H1N1) virus + Influenza A (H3N2) virus + Influenza B virus
Quadrivalent= Trivalent + additional influenza B strain